schema:articleBody
| - Tokyo's benchmark Nikkei index recovered early losses and closed higher Thursday on tech rallies, with sentiment sustained by the acceleration of Japan's vaccination drive. The Nikkei 225 index rose 0.34 percent, or 97.76 points, to 28,958.56, but the broader Topix index edged down 0.02 percent, or 0.41 points, to 1,956.73. "Tech shares led today's gains," Toshikazu Horiuchi, a broker at IwaiCosmo Securities, told AFP. "The acceleration of vaccine delivery also supported buying sentiment." Investors' focus was shifting to the key US consumer price index and a European Central Bank meeting, brokers said. "The ECB is likely in no rush to deliver a taper message," Tapas Strickland, senior analyst at National Australia Bank, said in a commentary. "The key question is whether the ECB provides guidance on the pace of (asset) purchases" in the third quarter, he added. The dollar fetched 109.53 yen in Asian afternoon trade against 109.63 yen in New York late Wednesday. Industrial robot maker Fanuc jumped 1.75 percent to 26,390 yen with chip-testing equipment manufacturer Tokyo Electron up 1.60 percent at 47,570 yen. Pharmaceutical firm Eisai dropped 7.01 percent to 10,000 yen on profit-taking after double-digit rises following the US approval of the Alzheimer's drug it developed with Biogen. Kewpie was up 1.09 percent to 2,577 yen after a report said the Japanese mayonnaise maker has developed a vegan version of scrambled eggs that are made of soy beans. kh-si/kaf/axn
|